Q1 Earnings Forecast for TVTX Issued By Wedbush
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Wedbush issued their Q1 2026 EPS estimates for shares of Travere Therapeutics in a research report issued on Wednesday, April 16th. Wedbush analyst L. Chico forecasts that the company will post earnings of ($0.02) per share for the quarter. The consensus estimate for Travere Therapeutics’ current full-year […]
